Literature DB >> 9655735

Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma.

K Rajakulasingam1, S Till, S Ying, M Humbert, J Barkans, M Sullivan, Q Meng, C J Corrigan, J Bungre, J A Grant, A B Kay, S R Durham.   

Abstract

FcepsilonRI receptors play an important role in allergen-induced mediator release and antigen presentation by mast cells, basophils, and monocyte/macrophages in atopic disorders. The expression of FcepsilonRI by tissue eosinophils in atopic asthma after allergen challenge has not been established. For this reason we attempted to identify mRNA and protein product + FcepsilonRIalpha eosinophils in cytospins made from bronchoalveolar lavage (BAL) from atopic asthmatics (n = 9) and nonatopic normal subjects (n = 4) 24 h after segmental challenge with allergen or diluent. Messenger RNA for FcepsilonRIalpha was determined using in situ hybridization and FcepsilonRIalpha protein expression by immunocytochemistry using a mouse monoclonal antibody 22E7. Colocalization of FcepsilonRIalpha receptors to eosinophils was performed using chromotrope 2R. When compared with a control challenge, segmental challenge with Dermatophagoides pteronyssinus induced significant BAL eosinophilia (p = 0.007). The total number of BAL FcepsilonRIalpha mRNA and protein-positive cells also increased in asthmatics, median values 2 (0.7-7.2) and 11.5 (0.6-65.0) x 10(6) cells (p = 0.02) and 0 (0-0.3 x 10(6)) and 3.1 x 10(6) (0.45 - 162.5 x 10(6)) cells (p = 0.007), respectively, for mRNA and protein. Net increases in FcepsilonRIalpha+ cells correlated with the net increases in BAL eosinophils (r = 0.98, p = 0.0001 for mRNA and r = 0.72, p = 0.02 for protein). Colocalization studies with chromotrope 2R revealed that only 4% of FcepsilonRIalpha+ cells were eosinophils after control challenge and, in contrast, 85 to 95% of FcepsilonRIalpha+ cells were eosinophils after allergen. There were no differences in the numbers of FcepsilonRIalpha+ cells or eosinophils in normal control subjects. Our results demonstrated that local endobronchial allergen provocation in atopic asthmatics results in increased synthesis and expression of FcepsilonRIalpha predominantly on BAL eosinophils.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655735     DOI: 10.1164/ajrccm.158.1.9708106

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

Review 1.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

Review 2.  Eosinophils as antigen-presenting cells in allergic upper airway disease.

Authors:  Praveen Akuthota; Haibin Wang; Peter F Weller
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-02

Review 3.  Immunoregulatory roles of eosinophils: a new look at a familiar cell.

Authors:  P Akuthota; H B Wang; L A Spencer; P F Weller
Journal:  Clin Exp Allergy       Date:  2008-08       Impact factor: 5.018

Review 4.  The immunoglobulin E receptor: expression and regulation.

Authors:  Edward R Conner; Sarbjit S Saini
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.919

Review 5.  Mast Cells and Their Progenitors in Allergic Asthma.

Authors:  Erika Méndez-Enríquez; Jenny Hallgren
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

Review 6.  Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.

Authors:  Gregorio Gomez
Journal:  Front Immunol       Date:  2019-02-07       Impact factor: 7.561

Review 7.  Respiratory viruses and eosinophils: exploring the connections.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Joseph B Domachowske
Journal:  Antiviral Res       Date:  2009-04-16       Impact factor: 5.970

Review 8.  Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases.

Authors:  Dean D Metcalfe; Ruby Pawankar; Steven J Ackerman; Cem Akin; Frederic Clayton; Franco H Falcone; Gerald J Gleich; Anne-Marie Irani; Mats W Johansson; Amy D Klion; Kristin M Leiferman; Francesca Levi-Schaffer; Gunnar Nilsson; Yoshimichi Okayama; Calman Prussin; John T Schroeder; Lawrence B Schwartz; Hans-Uwe Simon; Andrew F Walls; Massimo Triggiani
Journal:  World Allergy Organ J       Date:  2016-02-11       Impact factor: 4.084

Review 9.  Eosinophils and Bacteria, the Beginning of a Story.

Authors:  Edna Ondari; Esther Calvino-Sanles; Nicholas J First; Monica C Gestal
Journal:  Int J Mol Sci       Date:  2021-07-27       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.